Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2013
|
| gptkbp:ATCCode |
A10BH08
|
| gptkbp:CASNumber |
850649-62-6
|
| gptkbp:chemicalFormula |
C18H21N5O2
|
| gptkbp:contraindication |
gptkb:diabetic_ketoacidosis
type 1 diabetes |
| gptkbp:drugClass |
DPP-4 inhibitor
|
| gptkbp:eliminationHalfLife |
21 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:genericName |
gptkb:alogliptin
|
| https://www.w3.org/2000/01/rdf-schema#label |
Nesina
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Takeda_Pharmaceutical_Company
|
| gptkbp:metabolism |
minimal hepatic metabolism
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
headache
upper respiratory tract infection nasopharyngitis |
| gptkbp:synonym |
alogliptin benzoate
|
| gptkbp:usedFor |
gptkb:type_2_diabetes_mellitus
|
| gptkbp:bfsParent |
gptkb:Takeda
gptkb:Takeda_(Japan) |
| gptkbp:bfsLayer |
6
|